{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T18:56:09Z","timestamp":1781549769264,"version":"3.54.5"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,6,15]]},"DOI":"10.7759\/cureus.110910","type":"journal-article","created":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T18:09:39Z","timestamp":1781546979000},"source":"Crossref","is-referenced-by-count":0,"title":["Serous Otitis Media Secondary to a Middle Ear Neuroendocrine Tumor of Five-Year Duration"],"prefix":"10.7759","author":[{"given":"Jose Rodrigo","family":"Alcantara Dzib","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose Carlos","family":"Rivera Caceres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia Berenice","family":"Bolado Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alondra Karent","family":"Balbuena Couti\u00f1o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rolando Adan","family":"Medina Pinto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1038\/s41574-020-00458-x","article-title":"Diagnostic and therapeutic advances in neuroendocrine tumours","volume":"17","author":"Caplin ME","year":"2021","unstructured":"Caplin ME, Ratnayake GM. Diagnostic and therapeutic advances in neuroendocrine tumours. Nat Rev Endocrinol. 2021, 17:81-2. 10.1038\/s41574-020-00458-x","journal-title":"Nat Rev Endocrinol"},{"key":"ref2","article-title":"Middle ear neuroendocrine tumour","author":"Bell D","year":"2022","unstructured":"Bell D, Mete O, Asa SL, Lott Limbach A. Middle ear neuroendocrine tumour. Head and Neck Tumours. 5th ed. International Agency for Research on Cancer, Lyon, France; 2022. 4:"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1002\/hed.26658","article-title":"Neuroendocrine neoplasms of the middle ear: unpredictable tumor behavior and tendency for recurrence","volume":"43","author":"van der Lans RJ","year":"2021","unstructured":"van der Lans RJ, Engel MS, Rijken JA, et al.. Neuroendocrine neoplasms of the middle ear: unpredictable tumor behavior and tendency for recurrence. Head Neck. 2021, 43:1848-53. 10.1002\/hed.26658","journal-title":"Head Neck"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.oraloncology.2021.105465","article-title":"Management and outcome of middle ear adenomatous neuroendocrine tumours: a systematic review","volume":"121","author":"Engel MS","year":"2021","unstructured":"Engel MS, van der Lans RJ, Jansen JC, et al.. Management and outcome of middle ear adenomatous neuroendocrine tumours: a systematic review. Oral Oncol. 2021, 121:105465. 10.1016\/j.oraloncology.2021.105465","journal-title":"Oral Oncol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1007\/s12022-022-09708-2","article-title":"Overview of the 2022 WHO classification of neuroendocrine neoplasms","volume":"33","author":"Rindi G","year":"2022","unstructured":"Rindi G, Mete O, Uccella S, et al.. Overview of the 2022 WHO classification of neuroendocrine neoplasms. Endocr Pathol. 2022, 33:115-54. 10.1007\/s12022-022-09708-2","journal-title":"Endocr Pathol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2024.1392610","article-title":"Middle ear neuroendocrine tumor with multiple brain metastases: a case report and literature review","volume":"14","author":"Sun Y","year":"2024","unstructured":"Sun Y, Zhang Y, Cai D, Zhang W, Yang Z. Middle ear neuroendocrine tumor with multiple brain metastases: a case report and literature review. Front Oncol. 2024, 14:1392610. 10.3389\/fonc.2024.1392610","journal-title":"Front Oncol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1007\/s12105-022-01450-9","article-title":"Update from the 5th edition of the World Health Organization Classification of Head and Neck Tumours: Tumours of the Ear","volume":"16","author":"Sandison A","year":"2022","unstructured":"Sandison A. Update from the 5th edition of the World Health Organization Classification of Head and Neck Tumours: Tumours of the Ear. Head Neck Pathol. 2022, 16:76-86. 10.1007\/s12105-022-01450-9","journal-title":"Head Neck Pathol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1097\/MOO.0000000000001075","article-title":"Contemporary review of middle ear adenomatous neuroendocrine tumors","volume":"33","author":"Shoman N","year":"2025","unstructured":"Shoman N. Contemporary review of middle ear adenomatous neuroendocrine tumors. Curr Opin Otolaryngol Head Neck Surg. 2025, 33:271-5. 10.1097\/MOO.0000000000001075","journal-title":"Curr Opin Otolaryngol Head Neck Surg"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1055\/s-0043-1777695","article-title":"Middle ear cavity and mastoid neuroendocrine tumor presenting as otomastoiditis with cholesteatoma: a clinicoradiological and histopathological correlation","volume":"22","author":"Chalikandy A","year":"2023","unstructured":"Chalikandy A, Basu S. Middle ear cavity and mastoid neuroendocrine tumor presenting as otomastoiditis with cholesteatoma: a clinicoradiological and histopathological correlation. World J Nucl Med. 2023, 22:310-5. 10.1055\/s-0043-1777695","journal-title":"World J Nucl Med"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1097\/MAO.0000000000001905","article-title":"Adenomatous neuroendocrine tumors of the middle ear: a multi-institutional investigation of 32 cases and development of a staging system","volume":"39","author":"Marinelli JP","year":"2018","unstructured":"Marinelli JP, Cass SP, Mann SE, et al.. Adenomatous neuroendocrine tumors of the middle ear: a multi-institutional investigation of 32 cases and development of a staging system. Otol Neurotol. 2018, 39:e712-21. 10.1097\/MAO.0000000000001905","journal-title":"Otol Neurotol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1111\/jne.13031","article-title":"Middle ear neuroendocrine tumours: insight into their pathogenesis, diagnosis and management","volume":"33","author":"Ratnayake GM","year":"2021","unstructured":"Ratnayake GM, Luong TV, Toumpanakis C, Caplin M, Grossman AB. Middle ear neuroendocrine tumours: insight into their pathogenesis, diagnosis and management. J Neuroendocrinol. 2021, 33:e13031. 10.1111\/jne.13031","journal-title":"J Neuroendocrinol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.4103\/ijri.IJRI_125_20","article-title":"111In-Octreoscan SPECT\/CT hybrid imaging and 68Ga-DOTANOC PET\/CT in neuroendocrine adenoma of the middle ear (NAME)","volume":"30","author":"Pontico M","year":"2020","unstructured":"Pontico M, Frantellizzi V, Cosma L, de Vincentis G. 111In-Octreoscan SPECT\/CT hybrid imaging and 68Ga-DOTANOC PET\/CT in neuroendocrine adenoma of the middle ear (NAME). Indian J Radiol Imaging. 2020, 30:400-4. 10.4103\/ijri.IJRI_125_20","journal-title":"Indian J Radiol Imaging"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.42296","article-title":"Middle ear neuroendocrine tumor mimicking as chronic otitis media","volume":"15","author":"Sukumaran Y","year":"2023","unstructured":"Sukumaran Y, Pol Ong Y, Siow Ping L, Ong CA, Narayanan P. Middle ear neuroendocrine tumor mimicking as chronic otitis media. Cureus. 2023, 15:e42296. 10.7759\/cureus.42296","journal-title":"Cureus"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1007\/s12105-022-01435-8","article-title":"Update from the 5th Edition of the World Health Organization Classification of Head and Neck Tumors: overview of the 2022 WHO Classification of Head and Neck Neuroendocrine Neoplasms","volume":"16","author":"Mete O","year":"2022","unstructured":"Mete O, Wenig BM. Update from the 5th Edition of the World Health Organization Classification of Head and Neck Tumors: overview of the 2022 WHO Classification of Head and Neck Neuroendocrine Neoplasms. Head Neck Pathol. 2022, 16:123-42. 10.1007\/s12105-022-01435-8","journal-title":"Head Neck Pathol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1007\/s00428-017-2155-6","article-title":"Middle ear adenomatous neuroendocrine tumors: a 25-year experience at MD Anderson Cancer Center","volume":"471","author":"Bell D","year":"2017","unstructured":"Bell D, El-Naggar AK, Gidley PW. Middle ear adenomatous neuroendocrine tumors: a 25-year experience at MD Anderson Cancer Center. Virchows Arch. 2017, 471:667-72. 10.1007\/s00428-017-2155-6","journal-title":"Virchows Arch"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1007\/s12105-018-0915-5","article-title":"Cholesteatoma pearls: practical points and update","volume":"12","author":"Castle JT","year":"2018","unstructured":"Castle JT. Cholesteatoma pearls: practical points and update. Head Neck Pathol. 2018, 12:419-29. 10.1007\/s12105-018-0915-5","journal-title":"Head Neck Pathol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1038\/modpathol.2014.109","article-title":"Morphologic and immunohistochemical features of malignant peripheral nerve sheath tumors and cellular schwannomas","volume":"28","author":"Pekmezci M","year":"2015","unstructured":"Pekmezci M, Reuss DE, Hirbe AC, et al.. Morphologic and immunohistochemical features of malignant peripheral nerve sheath tumors and cellular schwannomas. Mod Pathol. 2015, 28:187-200. 10.1038\/modpathol.2014.109","journal-title":"Mod Pathol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1093\/jnen\/nlx008","article-title":"Immunohistochemical approach to the differential diagnosis of meningiomas and their mimics","volume":"76","author":"Boulagnon-Rombi C","year":"2017","unstructured":"Boulagnon-Rombi C, Fleury C, Fichel C, Lefour S, Marchal Bressenot A, Gauchotte G. Immunohistochemical approach to the differential diagnosis of meningiomas and their mimics. J Neuropathol Exp Neurol. 2017, 76:289-98. 10.1093\/jnen\/nlx008","journal-title":"J Neuropathol Exp Neurol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1007\/s12105-022-01521-x","article-title":"Top 10 histological mimics of neuroendocrine carcinoma you should not miss in the head and neck","volume":"17","author":"Juhlin CC","year":"2023","unstructured":"Juhlin CC, Bal M. Top 10 histological mimics of neuroendocrine carcinoma you should not miss in the head and neck. Head Neck Pathol. 2023, 17:66-84. 10.1007\/s12105-022-01521-x","journal-title":"Head Neck Pathol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/497967-serous-otitis-media-secondary-to-a-middle-ear-neuroendocrine-tumor-of-five-year-duration","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T18:09:40Z","timestamp":1781546980000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/497967-serous-otitis-media-secondary-to-a-middle-ear-neuroendocrine-tumor-of-five-year-duration"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,15]]},"references-count":19,"URL":"https:\/\/doi.org\/10.7759\/cureus.110910","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6,15]]}}}